Vytorin fails to meet main goal of heart study (Reuters)Reuters - The cholesterol fighter Vytorin sold
by Merck & Co Inc and Schering-Plough Corp failed to meet the
main goal of improving outcomes in a closely-watched heart
study, according to data presented on Monday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/vytorin_study_dc.html